Login / Signup

High serum interleukin-34 level is a predictor of poor prognosis in patients with non-viral hepatocellular carcinoma.

Yu NodaTakumi KawaguchiMasaaki KorenagaSachiyo YoshioSho KomukaiMasahito NakanoTakashi NiizekiHironori KogaAtsushi KawaguchiTatsuya KantoTakuji Torimura
Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2019)
Interleukin-34 was an independent factor for survival of non-viral HCC patients. Interleukin-34 might be associated with prognosis through tumor and hepatic fibrosis factors.
Keyphrases
  • poor prognosis
  • long non coding rna
  • end stage renal disease
  • sars cov
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors